Goldman Sachs Maintains Buy on XP, Lowers Price Target to $27
Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $31 to $27.
Follow the latest XP Inc. (XP) news and market headlines alongside the live XP price. Stay informed on what's moving XP.
Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $31 to $27.
Nvidia, Disney and Home Depot earnings loom; XP missed EPS but beat revenue, while Aecom topped estimates and raised its dividend.
XP (NASDAQ:XP) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.53 by 1.89 percent. This is a 15.56 percent increase over earnings of $0.45 per share from the same period
KindlyMD, Inc. (NAKA) reported a quarterly loss of $1.4 per share, significantly worse than the consensus estimate of $0.49 loss, representing a -185.71% earnings surprise. The company also posted negative revenues of -$1.93 million, missing estimates by 111.08%. With a Zacks Rank #4 (Sell) rating and the stock down 55.5% year-to-date, the company faces headwinds from unfavorable estimate revisions and an underperforming industry.
Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $36 to $31.
Solana Company reported a quarterly loss of $0.06 per share, missing consensus estimates of $0.01 loss, representing a -500% earnings surprise. Revenue of $3.36 million exceeded estimates by 17.90%, but the company has underperformed the S&P 500 by 36.9% year-to-date. Despite the miss, the stock holds a Zacks Rank #2 (Buy) rating based on favorable estimate revisions. XP Inc. is expected to report Q3 results on November 16 with anticipated earnings of $0.53 per share.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to XP, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.